Cytodyn Inc (CYDY)

[stockorus]

guarantees the 13D is bringing to the table are 1) delaying current progress

I believe this. Management right now has a clearly presented plan for this year and is making progress.

Dose report done, NASH trial 60-patient enrollment completed, finished application to ANVISA for Brazil trials, Cancer trial upgraded to phase 2, Phase 2 for LH complete.

Looking forward to next steps in BLA submission and completion as planned. Trial results in NASH and Cancer (not sure about timeline in this). Apply to FDA for phase 3 in LH. If FDA okays, then LH Ph 3 trial initiated this year and likely completed. If ANVISA okays, then Brazil trials completed this year. Results by year end for covid and may be for LH, NASH, Cancer (at least some prelim results?) They are also planning for BTD for either Cancer or LH.

If Leronlimab actually works, then there is good chance we will see it in the trial results of some of these indications. Management is doing its job well on this front for now and as we see ahead this year. Need to stay the course and see things through.